Expert hematologist-oncologists review treatment options for patients with myeloproliferative neoplasms and consider patient and disease factors that inform the selection of optimal therapy.
EP. 1: Overview of Myeloproliferative Neoplasms
A comprehensive overview of myeloproliferative neoplasms followed by insight on the differences between essential thrombocytopenia, polycythemia vera, and myelofibrosis.
EP. 2: Myeloproliferative Neoplasms: Testing, Workup, and Diagnosis
Broad perspective on diagnosis of the myeloproliferative neoplasms via optimal workup and molecular testing.
EP. 3: Important Pathways and Biomarkers in Myeloproliferative Neoplasms
Expert hematologist-oncologists share insight on the pathways driving myeloproliferative neoplasms and biomarkers that may be targeted with novel therapy.
EP. 4: Treatment Armamentarium for Polycythemia Vera
Centering discussion on polycythemia vera, Rami S. Komrokji, MD, and Pankit Vachhani, MD, share an in-depth review of cornerstone therapies in this setting.
EP. 5: Selecting and Sequencing Therapy in Patients With Polycythemia Vera
Considerations for the selection of optimal therapy in patients with polycythemia vera, and how these novel agents may be sequenced in the event of disease progression.
EP. 6: Novel Therapies Being Investigated in Polycythemia Vera
Before closing out their review of polycythemia vera management, expert hematologist-oncologists highlight novel therapies in the pipeline.
EP. 7: Identifying the Categories of Myelofibrosis
Shifting their attention to myelofibrosis, Rami S. Komrokji, MD, and Pankit Vachhani, MD, define differences between various subsets of disease.
EP. 8: Treatment Paradigm for Myelofibrosis
A review of the treatment armamentarium for patients with myelofibrosis in the context of clinical trial data supporting use of these agents.
EP. 9: Practical Use of Targeted Therapy in Patients With Myelofibrosis
Focusing on real-world management of myelofibrosis, experts share insight on how they would select and sequence therapies within the current paradigm.
EP. 10: Novel Therapies Being Investigated in Myelofibrosis
Key opinion leaders provide a comprehensive review of agents under investigation, alone or in combination, in patients with myelofibrosis.
EP. 11: Myeloproliferative Neoplasms: Future Directions in Care
Closing out their discussion on the management of myeloproliferative neoplasms, Rami S. Komrokji, MD, and Pankit Vachhani, MD, look toward the future treatment paradigm.
2 Commerce Drive Cranbury, NJ 08512